Eli Lilly will soon launch Mounjaro KwikPen in India. This follows regulatory approval for the diabetes and obesity drug. The ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

Eli Lilly is set to launch Mounjaro in KwikPen, a user-friendly, prefilled pen for weekly administration, in India, following ...

New data from a Phase 3 trial show that the daily anti-obesity pill may be as safe and effective as drugs like Mounjaro and ...

Eli Lilly ( LLY 0.82%) has been a great growth pick for investors over the past few years. The pharma company, thanks to its ...

The once-monthly drug is still under study but could provide added convenience and another option for patients.

However, if you're planning to ask your GP to prescribe it, are you actually eligible and do you meet the very specific ...

GPs across England will, for the first time, be able to prescribe a new weight loss injection on the NHS from Monday, as the ...

INDIANAPOLIS, June 16, 2025 /PRNewswire/ -- Eli Lilly and Company today announced that the highest approved doses of Zepbound (tirzepatide)—12.5 mg and 15 mg—will soon be available in single ...

About Zepbound (tirzepatide) injection Zepbound is the first and only dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist obesity medication.

GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...